Which of the following is NOT a treatment for coronary vasospasm?

Prepare for the COMAT Foundational Biomedical Science Exam with comprehensive questions. Study with flashcards and detailed explanations to boost your exam readiness and understanding.

Sildenafil is not typically used as a treatment for coronary vasospasm. It is primarily known as a phosphodiesterase type 5 (PDE5) inhibitor, commonly used to treat erectile dysfunction and pulmonary arterial hypertension. While sildenafil can induce vasodilation in the pulmonary vasculature, its effect on coronary vessels is not established as a primary treatment for vasospasm.

In contrast, diltiazem and verapamil are both calcium channel blockers that help relieve coronary vasospasm by relaxing the smooth muscles of blood vessels, thereby reducing coronary artery constriction. These medications increase blood flow and reduce the frequency and severity of vasospasm episodes.

Statins, while primarily used for their cholesterol-lowering effects, have been shown to have beneficial effects on endothelial function and vascular stability, which can also support the management of coronary artery disease and potentially reduce vasospasms indirectly. However, their primary role is not specifically for treating vasospasm itself.

Therefore, while diltiazem and verapamil directly target the mechanism of vasospasm, and statins contribute to overall cardiovascular health, sildenafil does not play a direct role in managing coronary vasospasm.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy